Axsome Therapeutics, Inc. (AXSM)
150.68
-1.37
(-0.90%)
USD |
NASDAQ |
Dec 29, 16:00
150.67
-0.01
(-0.01%)
After-Hours: 20:00
Axsome Therapeutics Shareholders Equity (Quarterly): 73.73M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 21.54B |
| ACADIA Pharmaceuticals, Inc. | 917.27M |
| Fortress Biotech, Inc. | 55.86M |
| TG Therapeutics, Inc. | 607.22M |
| Karyopharm Therapeutics, Inc. | -269.26M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 669.25M |
| Total Liabilities (Quarterly) | 595.52M |
| Debt to Equity Ratio | 2.965 |
| Current Ratio | 1.569 |
| Net Debt Paydown Yield | -0.09% |